TNF and focal segmental glomerulosclerosis: The present study shows that serum TNFα is significantly elevated in 96 FSGS patients compared to healthy controls (Fig 3); however, the levels of TNFα do not correlate with serum podocyte toxicity in the FAC assay or renal impairment (eGFR).